Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Tissue Engineered - Skin Substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue engineering for wound care management is the use of mechanical and chemical processing of materials to manufacture products that may substitute or replace all or some components that make up a normal skin (e.g. epidermis and/or dermis, cells and matrix).

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Engineered - Skin Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Engineered - Skin Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to-
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Engineered - Skin Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Tissue Engineered - Skin Substitutes Overview
  • Products under Development
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
      • Table Figure 1: Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
      • Table Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Segment
      • Table Figure 2: Tissue Engineered - Skin Substitutes - Pipeline Products by Segment
      • Table Tissue Engineered - Skin Substitutes - Pipeline Products by Segment
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Territory
      • Table Figure 3: Tissue Engineered - Skin Substitutes - Pipeline Products by Territory
      • Table Tissue Engineered - Skin Substitutes - Pipeline Products by Territory
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path
      • Table Figure 4: Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path
      • Table Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date
      • Table Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date
    • Tissue Engineered - Skin Substitutes - Ongoing Clinical Trials
      • Table Figure 6: Tissue Engineered - Skin Substitutes - Ongoing Clinical Trials
      • Table Tissue Engineered - Skin Substitutes - Ongoing Clinical Trials
  • Tissue Engineered - Skin Substitutes - Pipeline Products under Development by Companies
    • Tissue Engineered - Skin Substitutes Companies - Pipeline Products by Stage of Development
      • Table Tissue Engineered - Skin Substitutes Companies - Pipeline Products by Stage of Development
    • Tissue Engineered - Skin Substitutes - Companies Pipeline Products by Stage of Development
      • Table Tissue Engineered - Skin Substitutes - Companies Pipeline Products by Stage of Development
  • Tissue Engineered - Skin Substitutes Companies and Product Overview
    • Acro Biomedical Co Ltd Company Overview
      • Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACRODDM - Product Status
        • Table ACRODDM - Product Description
        • Table ACRODDMG - Product Status
        • Table ACRODDMG - Product Description
        • Table ACRODDMP - Product Status
        • Table ACRODDMP - Product Description
    • Adept Medical Ltd Company Overview
      • Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Plastic Surgery Graft - Product Status
        • Table Plastic Surgery Graft - Product Description
    • AGAM Biological Products Company Overview
      • AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview
        • Table AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview
        • Table Skin Substitute - Product Status
        • Table Skin Substitute - Product Description
    • Agenta Biotechnologies Inc (Inactive) Company Overview
      • Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Mesh - Tissue Support - Product Status
        • Table Implantable Mesh - Tissue Support - Product Description
        • Table Skin Graft - Post-Burns - Product Status
        • Table Skin Graft - Post-Burns - Product Description
    • Amnio Technology LLC Company Overview
      • Amnio Technology LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amnio Technology LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table PalinGen Flo - Product Status
        • Table PalinGen Flo - Product Description
        • Table Amnio Technology LLC - Ongoing Clinical Trials Overview
        • Table PalinGen Flo - A Prospective, Multicenter, Randomized, Controlled Clinical Investigation of Palingen Flow Amniotic Tissue Allograft to Assess Safety, Tolerability, and Preliminary Efficacy for the Treatment of Chronic Lower Extremity Cutaneous Ulcers Compared to Standard of Care
    • Boston Children's Hospital Company Overview
      • Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Mesostructured Polymer Membrane - Product Status
        • Table Biodegradable Mesostructured Polymer Membrane - Product Description
        • Table Fetal Tissue Engineered Patch - Product Status
        • Table Fetal Tissue Engineered Patch - Product Description
    • China Regenerative Medicine International Ltd Company Overview
      • China Regenerative Medicine International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Regenerative Medicine International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acellular Amniotic Membrane - Product Status
        • Table Acellular Amniotic Membrane - Product Description
        • Table Recombinant Human Acellular Dermal Matrix - Product Status
        • Table Recombinant Human Acellular Dermal Matrix - Product Description
    • Cutiss AG Company Overview
      • Cutiss AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cutiss AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table denovoSkin - Product Status
        • Table denovoSkin - Product Description
    • Elanix Biotechnologies AG Company Overview
      • Elanix Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Elanix Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table First Cover Acute - Product Status
        • Table First Cover Acute - Product Description
        • Table First Cover Chronic - Product Status
        • Table First Cover Chronic - Product Description
    • Indian Institute of Technology Delhi Company Overview
      • Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bio-Inspired Bi-Layer Polymeric Hybrid Scaffold - Product Status
        • Table Bio-Inspired Bi-Layer Polymeric Hybrid Scaffold - Product Description
    • Kerecis ehf Company Overview
      • Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kerecis Omega3 - Battlefield Wounds - Product Status
        • Table Kerecis Omega3 - Battlefield Wounds - Product Description
        • Table Kerecis Omega3 - Third-Degree Burns - Product Status
        • Table Kerecis Omega3 - Third-Degree Burns - Product Description
    • Lattice Biologics Ltd Company Overview
      • Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MarBrane - Product Status
        • Table MarBrane - Product Description
        • Table Skin + ECM - Product Status
        • Table Skin + ECM - Product Description
    • LifeCell Corp Company Overview
      • LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table AlloDerm Select - Non-Breast Applications - Product Status
        • Table AlloDerm Select - Non-Breast Applications - Product Description
    • Merakris Therapeutics LLC Company Overview
      • Merakris Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Merakris Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dermacyte - Product Status
        • Table Dermacyte - Product Description
        • Table Merakris Therapeutics LLC - Ongoing Clinical Trials Overview
        • Table Dermacyte - A Two Part, Randomized Study of Dermacyte Amniotic Wound Care Liquid for the Treatment of Nonhealing Venous Stasis Ulcers
    • MiMedx Group Inc Company Overview
      • MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AMNIOEFFECT - Product Status
        • Table AMNIOEFFECT - Product Description
        • Table AmnioFix Injectable - Achilles Tendonitis - Product Status
        • Table AmnioFix Injectable - Achilles Tendonitis - Product Description
        • Table AmnioFix Injectable - Chronic Cutaneous Ulcer - Product Status
        • Table AmnioFix Injectable - Chronic Cutaneous Ulcer - Product Description
        • Table AmnioFix Injectable - Knee OA Pain - Product Status
        • Table AmnioFix Injectable - Knee OA Pain - Product Description
        • Table AmnioFix Injectable - Plantar Fasciitis - Product Status
        • Table AmnioFix Injectable - Plantar Fasciitis - Product Description
        • Table AmnioFix Injectable - Pressure Ulcer - Product Status
        • Table AmnioFix Injectable - Pressure Ulcer - Product Description
        • Table EpiFix Amniotic Membrane Allograft - Product Status
        • Table EpiFix Amniotic Membrane Allograft - Product Description
        • Table MiMedx Group Inc - Ongoing Clinical Trials Overview
        • Table EpiFix Amniotic Membrane Allograft - Clinical Evaluation of EpiFix in venous leg ulcers ("VLUs")
        • Table EpiFix Amniotic Membrane Allograft - Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane
        • Table EpiFix Amniotic Membrane Allograft - The Registry of Cellular and Tissue Based Therapies for Chronic Wounds and Ulcers
        • Table AmnioFix Injectable - Plantar Fasciitis - A Phase III, Prospective, Double-blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Plantar Fasciitis
        • Table AmnioFix Injectable - Achilles Tendonitis - A Phase III Achilles Tendonitis Clinical Study of Investigational New Drug (IND)
        • Table AmnioFix Injectable - Achilles Tendonitis - A Phase III, Prospective, Double-blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis
        • Table AmnioFix Injectable - Knee OA Pain - A Phase IIB, Prospective, Double-blinded, Randomized Controlled Trial of the Micronized Dehydrated Human Amnion Chorion Membrane Injection as Compared to Saline Placebo Injection in the Treatment of Osteoarthritis of the Knee
    • Novadip Biosciences SA Company Overview
      • Novadip Biosciences SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novadip Biosciences SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table NVD-X2 - Product Status
        • Table NVD-X2 - Product Description
    • Organogenesis Holdings Inc Company Overview
      • Organogenesis Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Organogenesis Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosynthetic Burn Wound Matrix - Product Status
        • Table Biosynthetic Burn Wound Matrix - Product Description
        • Table Dermagraft - Epidermolysis Bullosa - Product Status
        • Table Dermagraft - Epidermolysis Bullosa - Product Description
        • Table Dermagraft - Rotator Cuff Repair - Product Status
        • Table Dermagraft - Rotator Cuff Repair - Product Description
        • Table Dermagraft - Venous Leg Ulcers Repair - Product Status
        • Table Dermagraft - Venous Leg Ulcers Repair - Product Description
        • Table VCT01 - Product Status
        • Table VCT01 - Product Description
        • Table Organogenesis Holdings Inc - Ongoing Clinical Trials Overview
        • Table Dermagraft - Venous Leg Ulcers Repair - The Registry of Cellular and Tissue Based Therapies for Chronic Wounds and Ulcers
    • Osiris Therapeutics Inc Company Overview
      • Osiris Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Osiris Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GrafixPL CORE - Product Status
        • Table GrafixPL CORE - Product Description
        • Table GrafixPL XC - Product Status
        • Table GrafixPL XC - Product Description
        • Table Stravix Meshed - Product Status
        • Table Stravix Meshed - Product Description
        • Table Stravix PL - Product Status
        • Table Stravix PL - Product Description
    • PolarityTE Inc Company Overview
      • PolarityTE Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolarityTE Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SkinTE - Cutaneous Ulcers - Product Status
        • Table SkinTE - Cutaneous Ulcers - Product Description
        • Table SkinTE - Diabetic Foot Ulcers - Product Status
        • Table SkinTE - Diabetic Foot Ulcers - Product Description
        • Table SkinTE - Pressure Injuries - Product Status
        • Table SkinTE - Pressure Injuries - Product Description
        • Table SkinTE - Traumatic Wounds - Product Status
        • Table SkinTE - Traumatic Wounds - Product Description
        • Table SkinTE - Venous Leg Ulcers - Product Status
        • Table SkinTE - Venous Leg Ulcers - Product Description
        • Table PolarityTE Inc - Ongoing Clinical Trials Overview
        • Table SkinTE - Diabetic Foot Ulcers - Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE: COVER DFUs
    • PolyNovo Biomaterials Pty Ltd Company Overview
      • PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NovoSorb BTM - Full Thickness Burn - Product Status
        • Table NovoSorb BTM - Full Thickness Burn - Product Description
        • Table Novosorb BTM - Wound Dressing - Product Status
        • Table Novosorb BTM - Wound Dressing - Product Description
        • Table PolyNovo Biomaterials Pty Ltd - Ongoing Clinical Trials Overview
        • Table Novosorb BTM - Wound Dressing - Clinical Study Evaluating NovoSorb SynPath for the Treatment of Non-healing Diabetic Foot Ulcers
        • Table NovoSorb BTM - Full Thickness Burn - A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries
        • Table NovoSorb BTM - Full Thickness Burn - Long-term Safety and Effectiveness Evaluation of Participants Treated with NovoSorb Biodegradable Temporising Matrix (BTM) for Dermal Repair: An Observational Cohort Study
    • Protein Genomics Inc Company Overview
      • Protein Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protein Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Elastatropin - Product Status
        • Table Elastatropin - Product Description
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Regenerative Replacement Tissue - Laryngeal Reconstruction - Product Status
        • Table Regenerative Replacement Tissue - Laryngeal Reconstruction - Product Description
    • Regenicin Inc Company Overview
      • Regenicin Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Regenicin Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NovaDerm - Burns - Product Status
        • Table NovaDerm - Burns - Product Description
        • Table NovaDerm - Diabetic Foot Ulcer - Product Status
        • Table NovaDerm - Diabetic Foot Ulcer - Product Description
        • Table NovaDerm - Reconstructive Surgery - Product Status
        • Table NovaDerm - Reconstructive Surgery - Product Description
    • Rensselaer Polytechnic Institute Company Overview
      • Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioprinted Skin Graft - Product Status
        • Table Bioprinted Skin Graft - Product Description
    • ROKIT Healthcare Inc Company Overview
      • ROKIT Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ROKIT Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dermal Patch Graft - Product Status
        • Table Dermal Patch Graft - Product Description
        • Table DFURegen - Product Status
        • Table DFURegen - Product Description
    • Santai Biotech Company Overview
      • Santai Biotech Pipeline Products & Ongoing Clinical Trials Overview
        • Table Santai Biotech Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3D Skin Tissue Scaffold - Product Status
        • Table 3D Skin Tissue Scaffold - Product Description
    • Smith & Nephew Plc Company Overview
      • Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table KERAGRAF - Product Status
        • Table KERAGRAF - Product Description
    • SMSbiotech Inc Company Overview
      • SMSbiotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SMSbiotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PEC-2S - Product Status
        • Table PEC-2S - Product Description
        • Table PEC-4I - Product Status
        • Table PEC-4I - Product Description
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
      • Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table PLGC-F-HA Scaffold - Product Status
        • Table PLGC-F-HA Scaffold - Product Description
        • Table Tissue Engineered Skin Substitute - Product Status
        • Table Tissue Engineered Skin Substitute - Product Description
        • Table Xenogenic Biograft - Product Status
        • Table Xenogenic Biograft - Product Description
    • Stratatech Corp Company Overview
      • Stratatech Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stratatech Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ExpressGraft - Antineoplastic - Product Status
        • Table ExpressGraft - Antineoplastic - Product Description
        • Table ExpressGraft - Sclerotic Digital Ulcers - Product Status
        • Table ExpressGraft - Sclerotic Digital Ulcers - Product Description
        • Table ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Status
        • Table ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Description
        • Table ExpressGraft C9T1 Skin Tissue - Product Status
        • Table ExpressGraft C9T1 Skin Tissue - Product Description
        • Table ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Status
        • Table ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Description
        • Table ExpressGraft Pro-Angiogenic - Venous Leg Ulcers - Product Status
        • Table ExpressGraft Pro-Angiogenic - Venous Leg Ulcers - Product Description
        • Table StrataGraft - Diabetic Foot Ulcers - Product Status
        • Table StrataGraft - Diabetic Foot Ulcers - Product Description
        • Table StrataGraft - Epidermolysis Bullosa - Product Status
        • Table StrataGraft - Epidermolysis Bullosa - Product Description
        • Table StrataGraft - Scar Revision - Product Status
        • Table StrataGraft - Scar Revision - Product Description
        • Table StrataGraft - Scleroderma Digital Ulcers - Product Status
        • Table StrataGraft - Scleroderma Digital Ulcers - Product Description
        • Table StrataGraft - Venous Leg Ulcer - Product Status
        • Table StrataGraft - Venous Leg Ulcer - Product Description
        • Table StrataGraft Skin Tissue - Pediatrics - Product Status
        • Table StrataGraft Skin Tissue - Pediatrics - Product Description
    • Tel Aviv University Company Overview
      • Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artificial Skin Graft - Product Status
        • Table Artificial Skin Graft - Product Description
    • Tissue Regenix Ltd Company Overview
      • Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table dCELL - Small Diameter Graft - Product Status
        • Table dCELL - Small Diameter Graft - Product Description
        • Table dCELL Human Dermis - Plastic Surgery - Product Status
        • Table dCELL Human Dermis - Plastic Surgery - Product Description
        • Table Dermapure - Acute Wounds - Product Status
        • Table Dermapure - Acute Wounds - Product Description
    • University of Edinburgh Company Overview
      • University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artificial Skin - Product Status
        • Table Artificial Skin - Product Description
    • Vericel Corp Company Overview
      • Vericel Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vericel Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epicel - Product Status
        • Table Epicel - Product Description
    • Worcester Polytechnic Institute Company Overview
      • Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Extracellular Matrix Scaffold - Product Status
        • Table Extracellular Matrix Scaffold - Product Description
    • XenoTherapeutics Inc Company Overview
      • XenoTherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table XenoTherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeno-Skin - Product Status
        • Table Xeno-Skin - Product Description
        • Table XenoTherapeutics Inc - Ongoing Clinical Trials Overview
        • Table Xeno-Skin - An Open-label Phase 1 Study to Evaluate the Safety and Tolerability of Xeno-Skin for Temporary Coverage of Severe and Extensive, Deep Partial and Full Thickness Burn Wounds
  • Tissue Engineered - Skin Substitutes- Recent Developments
    • May 10, 2022: Biostage Schedules Conference Call and Webcast for Q1 2022 Results
    • May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022
    • May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results
    • Apr 28, 2022: Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022
    • Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update
    • Apr 08, 2022: Orthofix Announces New Business Unit President
    • Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
    • Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference
    • Mar 31, 2022: Smith & Nephew announces Directorate Change
    • Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
    • Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results
    • Feb 28, 2022: MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results
    • Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer
    • Feb 10, 2022: Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25 2022
    • Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
    • Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company's director and board secretary
    • Jan 10, 2022: Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results
    • Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company
    • Dec 14, 2021: Orthofix Announces Appointment of Thomas A. West to Board of Directors
    • Dec 03, 2021: Printing Technique creates effective skin equivalent, heals wounds
    • Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences
    • Nov 05, 2021: Orthofix Reports Third Quarter 2021 Results
    • Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
    • Nov 03, 2021: Orthofix Announces Participation in Upcoming Credit Suisse and Stifel Healthcare Conferences
    • Nov 02, 2021: MIMEDX Announces Third Quarter 2021 Operating and Financial Results
    • Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
    • Oct 27, 2021: Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 5, 2021
    • Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
    • Oct 14, 2021: SINTX Technologies Shares Q3 2021 Revenue Update
    • Oct 14, 2021: MIMEDX to Host Virtual Investor Day on December 7, 2021
    • Sep 23, 2021: Orthofix Announces Appointment of Wayne Burris to Board of Directors
    • Sep 20, 2021: Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
    • Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
    • Aug 03, 2021: MIMEDX Announces Second Quarter 2021 Operating and Financial Results
    • Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results
    • Jul 29, 2021: Smith & Nephew announces Half-year Report
    • Jul 28, 2021: Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 6, 2021
    • Jul 20, 2021: MIMEDX to Host Second Quarter 2021 Operating and Financial Results Conference Call on August 4
    • Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
    • Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results
    • Jun 15, 2021: New study demonstrates potential for MIMEDX Purion processed dehydrated human amnion/chorion membrane to modulate pathological scar tissue formation
    • Jun 10, 2021: Worcester Polytechnic Institute Names Andrew Aberdale Board Chair
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings